Originally developed as diabetes medications, new glucagon-like peptide-1 (GLP-1) medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) suppress a patients appetite, slow gastric emptying, and help the pancreas increase its production of insulin to regulate blood sugar
According to the Summary of Product Characteristics for Ozempic approved by the MHRA and the European Medicines Agency's European Public Assessment Report (EPAR), urinary tract infections are not listed as a known side effect of semaglutide
Both rods and cones shed approximately 10% of their OS daily, and the discarded OS tips are ingested by the RPE 25
No prescription is required, as our products are sold strictly for in-vitro laboratory research and are not classified as medications or dietary supplements
Why Did the Retail Pharmacies Segment Dominate the Market in 2024